Schedule 13D ownership disclosure

INNOVUS PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 45778V106

Event date: 2018-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-19-000206
Form type
SC 13D
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Jan 09, 2019
Reporting period
Dec 30, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub